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Abstract 
Background: Plasmodium vivax apical membrane antigen‑1 (PvAMA‑1) is a leading candidate antigen for blood 
stage malaria vaccine. However, antigenic variation is a major obstacle in the development of an effective vaccine 
based on this antigen. In this study, the genetic structure and the effect of natural selection of PvAMA‑1 among 
Korean P. vivax isolates were analysed.
Methods: Blood samples were collected from 66 Korean patients with vivax malaria. The entire PvAMA‑1 gene was 
amplified by polymerase chain reaction and cloned into a TA cloning vector. The PvAMA‑1 sequence of each isolate 
was sequenced and the polymorphic characteristics and effect of natural selection were analysed using the DNASTAR, 
MEGA4, and DnaSP programs.
Results: Thirty haplotypes of PvAMA‑1, which were further classified into seven different clusters, were identified 
in the 66 Korean P. vivax isolates. Domain II was highly conserved among the sequences, but substantial nucleotide 
diversity was observed in domains I and III. The difference between the rates of non‑synonymous and synonymous 
mutations suggested that the gene has evolved under natural selection. No strong evidence indicating balancing or 
positive selection on PvAMA‑1 was identified. Recombination may also play a role in the resulting genetic diversity of 
PvAMA‑1.
Conclusions: This study is the first comprehensive analysis of nucleotide diversity across the entire PvAMA‑1 gene 
using a single population sample from Korea. Korean PvAMA‑1 had limited genetic diversity compared to PvAMA‑1 
in global isolates. The overall pattern of genetic polymorphism of Korean PvAMA‑1 differed from other global isolates 
and novel amino acid changes were also identified in Korean PvAMA‑1. Evidences for natural selection and recom‑
bination event were observed, which is likely to play an important role in generating genetic diversity across the 
PvAMA‑1. These results provide useful information for the understanding the population structure of P. vivax circulat‑
ing in Korea and have important implications for the design of a vaccine incorporating PvAMA‑1.
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Background
Plasmodium vivax is the most prevalent human malaria 
parasite globally and is responsible for a large propor-
tion of the global malaria burden, especially in regions 
outside of Africa [1]. Although it has been neglected as a 
benign infection, P. vivax causes serious clinical illnesses 
including respiratory distress, severe anemia, coma and 
even death [2, 3]. Moreover, it has recently re-emerged in 
many temperate regions from where it had been largely 
eradicated during global malaria control campaigns. The 
emergence of drug resistance strains also complicates the 
burden of the parasite [4, 5]. Considering the enormous 
socio-economic impact of P. vivax on humans, develop-
ment of an effective vaccine is an important concern in 
control and elimination strategies. However, no effective 
vaccine is yet available and the antigenic diversity present 
in wild-type isolates, which has led to the failure of sev-
eral licensed and tested malaria vaccines, has been rec-
ognized as a major concern in developing a successful 
vaccine.
Apical membrane antigen-1 (AMA-1) is a type 1 inte-
gral membrane protein that is expressed in the late schiz-
ont stage of malaria parasites [6]. It is initially synthesized 
in the micronemes of the apical complex of merozoites 
and is transported to the surface of parasite just prior 
to erythrocyte invasion, where it undergoes proteolytic 
cleavage [7, 8]. Although the precise role of AMA-1 is not 
fully understood, it is believed to be essential in erythro-
cyte invasion [9]. AMA-1 consists of a signal sequence, 
a cysteine-rich ectodomain, a conserved cytoplasmic 
region and a transmembrane region. The ectodomain is 
further divided into three distinct domains (domains I, 
II and III) by disulfide bridges [10]. The ectodomain of 
AMA-1 is very immunogenic and a high antibody titer 
against the domain is produced in humans who are natu-
rally infected with malaria parasites [11–14]. Antibodies 
against AMA-1 effectively inhibit erythrocyte invasion 
[15–17]. Therefore, AMA-1 has been considered as a 
promising candidate antigen for blood stage malaria vac-
cine [18, 19].
Although it is recognized that AMA-1 is less vari-
able than the other blood stage malaria vaccine can-
didate antigens such as merozoite surface protein 
antigens (MSPs) and circumsporozoite protein (CSP), 
it also shows sequence variations among global malaria 
parasites [20–23]. In P. falciparum, most of the genetic 
polymorphisms are concentrated in domain I [20, 21, 
24], while the majority of the polymorphic patterns of 
AMA-1 occur in domains I and II in P. vivax [22–27]. 
These polymorphisms result in amino acid changes in the 
natural population, indicating that PvAMA-1 is under 
natural selection, may be a result of host immune pres-
sure [23, 26].
In this study, the population genetic structure and 
natural selection of PvAMA-1 among Korean P. vivax 
isolates was analysed. A higher rate of polymorphic pat-
terns and evidence of natural selection were identified 
in domains I and III. The Korean PvAMA-1 showed dif-
ferent polymorphic patterns compared to other global 
isolates. Recombination also likely has been important 
in generating genetic diversity across the PvAMA-1 
sequences. These results provide useful information for 
the understanding of the population structure of P. vivax 
circulating in Korea and have important implications for 
the design of a vaccine incorporating PvAMA-1.
Methods
Blood samples and study areas
A total of 66 blood samples from Korean patients with 
uncomplicated P. vivax were collected at endemic areas 
between 2009 and 2011. The P. vivax infection was con-
firmed by microscopic examination of thin and thick 
blood smears and species-specific polymerase chain 
reaction (PCR) [28]. All the patients resided in malaria 
endemic regions, northwestern part of Gyeonggi province 
near DMZ in Korea, and have not been abroad at least 
in past 2 years when their blood samples were collected. 
The collected blood was separated into packed cells and 
plasma and then stored at −80  °C until use. Informed 
consent was obtained from all of the patients before blood 
collection. The study protocol was approved by the Ethics 
Committee of the Inha University School of Medicine.
Amplification and sequencing analysis of the PvAMA‑1
Genomic DNA of parasite was extracted from 200 µl of 
whole blood sample using the QIAamp DNA Blood Kit 
(Qiagen, Hilden, Germany). The entire PvAMA-1 gene 
was amplified using two rounds of PCR. The primers 
were designed based on conserved regions of PvAMA-1 
sequences of Sal I (AF063138) and Belem (EU395595). 
The forward and reverse primers used for the first 
round of PCR were 5′-GCAGAGAGAGCAAACC 
AAATCG-3′ and 5′-GCAAGCGAGTTGGCCAAGC 
AAA-3′. The primers used for the nested PCR were 
5′-ATGAATAAAATATACTACATAATCTTTTTA-3′ 
and 5′-TTAGTAGTATGGCTTCTCCATCAG-3′. The 
following thermal cycling conditions were used for both 
amplifications: 94  °C for 5  min; 30 cycles of 94  °C for 
1 min, 52  °C for 1 min and 72  °C for 2 min, and a final 
extension at 72  °C for 10 min. To minimize the nucleo-
tide mis-incorporation in the sequences during PCR 
amplification, Ex Taq DNA polymerase (Takara, Otsu, 
Japan), which has a proofreading activity, was used in all 
PCR process. Each resulting PCR product was resolved 
on a 1.2 % agarose gel, purified from the gel, and ligated 
into the T&A cloning vector (Real Biotech Corporation, 
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Banqiao City, Taiwan). Each ligation mixture was trans-
formed into Escherichia coli DH5α competent cells and 
positive clones with the appropriate insert were selected 
by colony PCR. The nucleotide sequences of the cloned 
insert were analysed by automatic DNA sequencing 
with M13 forward and M13 reverse primers. Sequenc-
ing analyses with two additional specific internal primers 
(5′-GAAGTTAAACGATATAGCTTTGTGCAG-3′ and 
5′-TCAACACTGTACAGATTCATGTTCCTC-3′) were 
also performed to obtain the sequences of central region 
of PvAMA-1. At least two clones from each isolate were 
sequenced to ensure sequencing accuracy, and some 
isolates underwent three- or four-fold sequence cover-
age to confirm the existence of rare polymorphisms. The 
nucleotide sequences reported in this study have been 
deposited in the GenBank database under the accession 
numbers (KM230319–KM230384).
Sequence and phylogenetic analysis of PvAMA‑1
The nucleotide and deduced amino acid sequences of 
PvAMA-1 were analysed using EditSeq and SeqMan 
in the DNASTAR package (DNASTAR, Madison, WI, 
USA). The phylogenetic tree was constructed using the 
neighbour-joining method in MEGA4 computational 
program [29]. Bootstrap proportions were used to assess 
the robustness of the tree with 1000 bootstrap replicates.
Sequence analysis
DNA sequence polymorphism analysis was performed 
on the 66 PvAMA-1 sequences. The number of seg-
regating sites (S), haplotypes (H), haplotype diversity 
(Hd), nucleotide diversity (π), and the average number 
of pair-wise nucleotide differences within the popula-
tion (K) were estimated using the DnaSP ver. 5.10.00 [30]. 
The π was calculated to estimate the step-wise diversity 
throughout the entire PvAMA-1 based on a sliding win-
dow of 100 bases with a step size of 25 bp. The rates of 
synonymous (dS) and non-synonymous (dN) substitu-
tions were estimated and were compared using the Z test 
(P < 0.05) in MEGA4 program [29] using Nei and Gojo-
bori’s method [31] with the Jukes and Cantor correction. 
To evaluate the neutral theory of evolution, the Tajima’s 
D value [32] and Fu and Li’s D and F statistics [33] were 
analysed using the DnaSP ver. 5.10.00 [30].
Recombination parameters and linkage disequilibrium
The recombination parameter (R), which included the 
effective population size and probability of recombina-
tion between adjacent nucleotides per generation, and 
the minimum number of recombination events (Rm) 
were determined using the DnaSP ver. 5.10.00 [30]. The 
linkage disequilibrium (LD) between the different poly-
morphic sites was computed based on the R2 index.
Results
Sequence polymorphism in Korean PvAMA‑1
Sixty-six PvAMA-1 sequences with 30 different haplo-
types were obtained from Korean P. vivax isolates. Phylo-
genetic analysis of the sequences classified the 66 Korean 
PvAMA-1 sequences into seven distinct clusters (clus-
ters A–G; Fig.  1). Nucleotide sequence analysis of the 
66 sequences compared to SalI (AF063138) revealed 66 
single nucleotide polymorphisms (SNPs) in the Korean 
PvAMA-1 sequences. The 22 SNPs were synonymous 
and the others were non-synonymous. The non-synony-
mous SNPs resulted in 44 dimorphic amino acid changes 
in 66 PvAMA-1 sequences (Fig.  2). Although these 
amino acid changes were not evenly distributed in each 
PvAMA-1 haplotype, four amino acid changes (D107A, 
K120R, N132D and E277K) were commonly found in all 
PvAMA-1 sequences (Fig. 2). L384P was commonly iden-
tified in the sequences in clusters A, B, C and D. E227V 
and S228D were highly conserved in sequences belong-
ing to clusters B, C, D, E, F and G. T191K and N445D 
were also highly conserved in sequences in clusters C, D, 
E, F and G. The other amino acid changes were randomly 
distributed in each haplotype or were conserved among 
the sequences that were classified into the same cluster. 
For example, R112T was identified only in the sequences 
clustered into clusters A and B. Meanwhile, K86R, 
E189K, R471G and K401R were conserved in cluster A, 
B, C and E, respectively.
These amino acid changes were mainly identified in 
domain I, but with significant rates in domains II and III. 
Six amino acid changes (Q25K, T31A, G491R, D520G, 
A540T and E545G) were found in the 5ʹ-terminal (5ʹ-T) 
or 3ʹ-terminal (3ʹ-T) region. Among the 44 dimorphic 
amino acid changes, 15 have been previously reported. 
The remaining 29 changes (Q25K, T31A, K61E, K86R, 
R88G, P90L, C94Y, V96A, F97L, H134R, T139A, M153T, 
L161V, T191K, C192R, R240C, I268V, R313G, V327M, 
K353R, C354R, K401R, D412G, I466T, R471G, G491R, 
D520G, A540T and E545G) are novel ones that have not 
been reported previously.
Comparison of amino acid polymorphisms of Korean 
PvAMA‑1 with global P. vivax isolates
Korean PvAMA-1 showed different patterns of amino 
acid polymorphisms compared to those from other geo-
graphical regions (Fig.  3). The most significant charac-
teristic in Korean PvAMA-1 was that four amino acid 
changes (D107A, K120R, N132D and E277K) were tightly 
conserved in all 66 PvAMA-1 sequences. E227V and 
S228D (63/66; 95.5  %, respectively), T191K and N445D 
(49/66; 74.2  %, respectively) and L384P (35/66; 53.03  %) 
also showed high level of polymorphic patterns. High 
frequency of D107A was also identified in PvAMA-1 
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Fig. 1 Phylogenetic analysis of the PvAMA‑1 sequences. The tree was constructed with 66 PvAMA‑1 sequences obtained from Korean P. vivax 
isolates using a neighbour‑joining method. The 66 sequences were divided into seven distinct clusters (cluster A–G). The tree was constructed using 
1000 bootstrap replicates
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sequences from India (63.6  %), Thailand (72.2  %), Papua 
New Guinea (PNG, 73.5  %) and Venezuela (69.9  %), but 
its frequency was low in the sequences from Iran (29.7 %) 
and Sri Lanka (17.4  %). K120R and E277K showed high 
level changes in the global PvAMA-1 sequences currently 
analysed. N132D was very frequent in India (81.8 %) and 
PNG (96.1 %), but was less than 50 % in Iran, Sri Lanka, 
Thailand and Venezuela. E227V and S228D changes were 
tightly linked in Korean PvAMA-1 sequences. Interest-
ingly, T191K and N445D, which were identified in high 
levels of frequency in Korean PvAMA-1, were not or rarely 
identified in PvAMA-1 sequences from other geographi-
cal areas. Meanwhile, R112K/T/S, L140I, E145A, P210S 
and R438H, which were highly polymorphic in PvAMA-1 
sequences from other geographical areas, were not identi-
fied or detected at low levels in Korean PvAMA-1.
Nucleotide diversity and natural selection
DNA sequence analyses were conducted to deter-
mine nucleotide diversity and genetic differentiation 
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Fig. 2 Sequence polymorphism of the PvAMA‑1 in Korean Plasmodium vivax isolates. The amino acid sequences of Korean PvAMA‑1 were com‑
pared to the Sal I sequence (AF063138). Identical amino acid residues are indicated by dots. The 44 non‑synonymous SNPs identified in 66 Korean 
PvAMA‑1 resulted in 44 amino acid changes, all of which were dimorphic. The amino acid changes were not evenly distributed in each PvAMA‑1 
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of PvAMA-1 in the Korean P. vivax isolates. The K 
value for the 1687 bp of full length PvAMA-1 was 8.07 
(Table 1). The highest nucleotide differences was identi-
fied at domain I (K = 4.856) and was the lowest at 5ʹ-T. 
The Hd for the entire PvAMA-1 sequences of 66 isolates 
was 0.961 ± 0.012. This value was higher in domain III 
than in domains I and II. The π of the entire PvAMA-1 
for the 66 Korean isolates was 0.00478  ±  0.00038. 
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Analysis of the π for the 5ʹ-T, domain I, domain II, 
domain III and 3ʹ-T indicated that most of the nucleo-
tide diversity was concentrated in domains I and III. 
The π value for each fragment was 0.00071  ±  0.00039 
(5ʹ-T), 0.00786 ± 0.00087 (domain I), 0.00240 ± 0.00030 
(domain II), 0.00601  ±  0.00054 (domain III) and 
0.00132  ±  0.00048 (3ʹ-T) (Table  1). Overall nucleotide 
diversity observed across the entire PvAMA-1 indi-
cated peak nucleotide diversity in domains I and III 
(Fig. 4a). To examine whether natural selection contrib-
uted to generation of the diversity in PvAMA-1 of the 
Korean P. vivax population, the rate of dN to dS was 
estimated using the Nei and Gojobori’s method [30]. 
The dN (0.00379) exceeded dS (0.00541), and the dN/dS 
ratio of 0.703 suggested that negative natural selection 
may be occurring in the PvAMA-1 of Korean P. vivax 
isolates (Table  1). To further analyse the natural selec-
tion occurs in PvAMA-1 of Korean P. vivax population, 
Tajima’s D test was performed. The estimated value was 
−1.4140 (P  >  0.10), indicating that PvAMA-1 is under 
population size expansion and/or purifying selection 
pressure (Table 1). The Fu and Li’s D and F values for the 
entire PvAMA-1 were also negative: −1.5383 (P > 0.10) 
and −1.2030 (P > 0.10), respectively (Table 1). Tajima’s D 
values for each fragment of PvAMA-1 also showed nega-
tive values: 5ʹ-T (−1.3151, P > 0.10), domain I (−1.1028, 
P > 0.10), domain II (−1.5941, 0.05 < P < 0.10), domain 
III (−0.5681, P  >  0.10) and 3ʹ-T (−1.9993, P  <  0.05). 
However, the middle region of domain I and the junc-
tion between domains II and III showed positive Tajima’s 
D values (Fig. 4b), indicating that the regions could be a 
dominant target of host immune response.
Recombination and linkage disequilibrium
For Korean PvAMA-1, the minimum number of recom-
bination events between adjacent polymorphic sites (Rm) 
was estimated as 3, whereas the R between adjacent site 
(Ra) and per gene (Rb) was 0.0056 and 9.5, respectively. 
The plausible recombination sites were predicted to be 
localized in domain I and domain III. These high values 
of the recombination parameters suggested that mei-
otic recombination may occur between sites, resulting 
in genetic diversity of PvAMA-1. The LD index (R2) also 
declined across PvAMA-1, suggesting that intragenic 
recombination may also be contributing the PvAMA-1 
diversity (Fig. 5).
Discussion
Vivax malaria re-emerged in Korea in 1993 near the 
demilitarized zone (DMZ) border with North Korea [34]. 
Since its re-emergence, the outbreak has spread into cit-
ies and counties adjacent to the DMZ and has persisted 
until now with fluctuating numbers of annual indigenous 
cases, with 32,300 official cases [35]. Understanding the 
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Fig. 4 Nucleotide diversity and natural selection of PvAMA‑1 in 
Korean isolates. a Nucleotide diversity. Sliding window analysis 
showed nucleotide diversity (π) values in 66 PvAMA‑1 sequences 
analysed. A window size of 100 bp and a step size of 25 bp were used. 
b Natural selection. Sliding window calculation of Tajima’s D statistic 
was performed for the 66 PvAMA‑1 sequences. A window size of 100 
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Fig. 5 Recombination event in PvAMA‑1. The linkage disequilibrium 
(LD) plot showed non‑random associations between the nucleotide 
variants in 66 Korean PvAMA‑1 sequences at different polymorphic 
sites. The R2 values were plotted against nucleotide distance using a 
two‑tailed Fisher’s exact test for statistical significance
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nature of the genetic population of P. vivax circulat-
ing in Korea is beneficial to knowledge of the nation-
wide parasite heterogeneity and in the implementation 
malaria control programs in the country. Moreover, this 
information is helpful for the development of an effec-
tive malaria vaccine. Several studies on genetic diver-
sity of polymorphic marker proteins including MSP-1, 
MSP-3α, MSP-3β and CSP in Korean P. vivax suggested 
that rapid dissemination of genetic structure of P. vivax 
is processed in recent years [36–42]. Characterization of 
genetic property of PvAMA-1 in Korean P. vivax isolates 
has also been analysed [43, 44], but these studies ana-
lysed sequence polymorphism restricted to partial region 
corresponding domain I and not the entire PvAMA-1. In 
the present study, the genetic polymorphisms and natural 
selection in the entire PvAMA-1 among P. vivax Korean 
isolates were analysed to gain an in-depth understanding 
of the nature of PvAMA-1 in Korean P. vivax population.
The 66 PvAMA-1 sequences obtained from Korean P. 
vivax isolates were classified into 30 different haplotypes, 
which were further clustered into seven distinct clusters. 
Compared to Sal I sequence, 66 SNPs, which resulted in 
44 dimorphic amino acid substitutions, were identified 
in Korean PvAMA-1. The majority of the amino acid 
changes clustered within PvAMA-1 domain I, as has 
been reported previously for P. vivax and P. falciparum 
AMA-1 [20–23, 26, 27, 45]. The 15 amino acid changes 
identified in Korean PvAMA-1 are comparable to those 
previously identified [22, 23, 26, 27], which suggests that 
the polymorphic sites are under high natural selection. 
The 29 amino acid changes were novel and have not been 
reported, even though they were detected with low fre-
quencies in Korean PvAMA-1. Compared to previously 
reported North Korea (EU395599) and South Korea 
(SK0814; GU476844) sequences, which are only two 
entire PvAMA-1 sequences currently available in Korean 
Peninsula-origin P. vivax, Korean PvAMA-1 sequences 
analysed in this study shared similar patterns of amino 
acid changes. All amino acid changes reported in the 
North Korea and South Korea sequences were com-
monly identified in all Korean PvAMA-1 sequences ana-
lysed currently. In particular, the four tightly conserved 
amino acid changes (D107A, K120R, N132D and E277K), 
which are the most outstanding characteristic found in 
Korean PvAMA-1 analysed in this study, were well-con-
served in the all the sequences. Based on the sequence 
polymorphism analyses of the current study, the North 
Korea sequence was most similar to the sequences 
belongs to cluster A, while the South Korea sequence 
was more closely related with the sequences of cluster 
D or G. Interestingly, Korean PvAMA-1 showed differ-
ent patterns of polymorphism compared to previously 
reported sequences from other geographical regions 
[22–27]. Although K120R/S and E277K were also identi-
fied at high frequencies (up to 50 %) in PvAMA-1 from 
other different geographical areas, D107A/N frequency 
was low in Iran (29.7 %) and Sri Lanka (17.4 %) and the 
N132D/G frequency was low in Iran (37.0 %), Sri Lanka 
(4.3  %), Thailand (17.1  %) and Venezuela (20.6  %) [22–
27]. S228D, which showed a high frequency (95.5  %) in 
Korean PvAMA-1, was identified with a high frequency 
only in Indian isolates (72.8  %) [25]. Meanwhile, the 
amino acid changes (R112K/T/S, L140I, E145A, P201S 
and R438H), which showed high frequencies in other 
geographical regions, were not identified or detected 
only with low levels of frequency in Korean PvAMA-1. 
Unlike the relatively even global distribution of PfAMA-1 
diversity [46, 47], substantial geographical differentia-
tion between populations was observed for PvAMA-1 
[23]. The results of this study also suggest that Korean 
PvAMA-1 showed different patterns of polymorphic 
nature compared to those of other geographical areas 
and substantial geographic differentiation was observed 
among global isolates.
Several studies have suggested that the most common 
polymorphic amino acid residues identified in PvAMA-1 
are located on one face of the protein, which suggests 
that this face is more exposed to the exterior environ-
ment and is accessible to host immune responses [21, 23, 
27, 48]. Consistent with the previous studies, the major-
ity of SNPs detected in Korean PvAMA-1 are exposed 
on one face of the protein. A recent study on the epitope 
mapping prediction of PvAMA-1 suggested that the 
potential B cell epitopes across the ectodomain [27]. 
Some of the SNPs identified in global P. vivax isolates, 
including E145K, P210S, R249H, G253E, K352E, R438H 
and N445D, overlap with the B-cell epitope regions. 
These amino acid changes may affect the protein struc-
ture by causing changes in charge and polarity of the 
protein and might help parasites to escape from host pro-
tective immunity [27]. No or few changes were observed 
in the corresponding amino acids in Korean PvAMA-1, 
but N445D was identified with a high frequency (74.2 %), 
which differs significantly from isolates from other dif-
ferent geographical areas. Three additional amino acid 
substitutions (Q380K, V382E and L384P/R) were also 
may alter protein structure by causing changes in protein 
polarity and hydrophilicity [27], which might decrease 
epitope binding scores or loss of the predicted linear B 
cell epitope either together or in combination with proxi-
mal polymorphisms [49]. Q380K and V382E were not 
identified in Korean PvAMA-1, but L384P was observed 
at a high frequency (53.3  %). Intrinsically unstructured/
disordered regions (IURs), which are widely identified in 
eukaryotic proteins, play important roles in many fun-
damental cell functions such as molecular recognition, 
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molecular assembly and protein modification [50, 51]. 
Plasmodium spp. also have many proteins containing 
IURs and these proteins have been considered impor-
tant in attachment and invasion of the parasite into red 
blood cells, although their specific functions remain to 
be defined [52]. Thereby overlap region of B-cell epitopes 
and IURs has been postulated more likely to represent a 
real antigenic/immunogenic region within a protein and 
the co-occurrence of both regions increases the chance 
of presenting this region with no secondary structure 
[52, 53]. The predicted overlap IUR and B-cell epitope, 
which comprises 18 amino acid residues (SASDQPTQY-
EEEMTDYQK), is highly antigenic during natural human 
infections and is an important antigenic region of the 
domain II of PvAMA-1 [27, 53]. This linear epitope was 
highly conserved in all Korean PvAMA-1 sequences, 
as it was strictly conserved in currently analysed global 
isolates [27]. This suggests a high degree of amino acid 
sequence conservation of the region among global P. 
vivax isolates and further supports the hypothesis that 
these amino acid sequences in domain II are subjected to 
strong purifying selection that might be used as a compo-
nent of a PvAMA-1-based vaccine.
The level of nucleotide diversity at entire PvAMA-1 
in Korean P. vivax isolates (π  =  0.00478) was rela-
tively lower than those for isolates from different geo-
graphical areas, including Iran (π = 0.00826), Sri Lanka 
(π = 0.00675), PNG (π = 0.0079), Venezuela (π = 0.0065) 
and Thailand (π  =  0.0089) [22, 23, 27]. Lower malaria 
transmission in Korea compared to other endemic 
countries may contribute to the lower genetic diversity 
observed in Korean PvAMA-1. These collective results 
are suggestive of a low level of genetic polymorphism 
occurring at Korean PvAMA-1. The nucleotide diversity 
was not evenly distributed across entire PvAMA-1. The 
5ʹ-T and 3ʹ-T showed low levels of nucleotide diversity, 
which suggests that the two regions are relatively well 
conserved in Korean PvAMA-1. A high level of nucleo-
tide diversity was observed in domain I and domain III 
in PvAMA-1 of Korean P. vivax isolates, different from 
previous reports that nucleotide diversity is highest in 
domains I and II of PvAMA-1 in Indian, Sri Lankan and 
Thailand P. vivax isolates [22, 26, 27]. This indicates that 
domain II is more conservative with lower frequency pol-
ymorphisms than domains I and III in Korean PvAMA-1, 
even though a cluster of SNPs was observed in domain 
II. Natural selection affected by host immune responses 
and recombination between genetically distinct malaria 
parasites during meiotic replication in the mosquito mid-
gut have been recognized as the two main mechanisms 
by which PvAMA-1 genetic diversity is generated and 
maintained [49]. The dN/dS for the entire length Korean 
PvAMA-1 was estimated to 0.703, suggesting that 
purifying selection pressure may act on the protein [54]. 
However, the dN/dS value of domain II was higher than 1 
(1.946), which implies that positive natural selection may 
be occurring in the domain. Negative values of Tajima’s 
D (−1.4140), Fu and Li’s D (−1.5383) and Fu and Li’s F 
(−1.2030) for entire Korean PvAMA-1 presently analysed 
imply an excess of low frequency polymorphisms indi-
cating population size expansion and/or purifying selec-
tion [31]. Each domain of Korean PvAMA-1 also showed 
negative values of Tajima’s D, Fu and Li’s D and Fu and 
Li’s F. These results clearly point to stronger diversifying 
selection, probably by host immune selection pressure, 
is working at Korean PvAMA-1. Meiotic recombina-
tion that occurs between the adjacent polymorphic sites 
drives allelic diversity of PvAMA-1 [22, 26]. Evidence of 
recombination event within the Korean PvAMA-1 was 
also observed, which supported by the decline of LD 
index R2 with increasing nucleotide distance, as consist-
ent with the previous studies.
Conclusions
A major concern in the development of effective 
malaria vaccine is genetic polymorphisms observed 
among global isolates. PvAMA-1 is one of the most 
promising candidates for malaria vaccine targeting 
the blood stages of P. vivax. Genetic investigation of 
Korean PvAMA-1 suggests that this antigen shows 
a limited antigenic diversity, but most of the major 
amino acid polymorphisms located on one face of the 
protein were commonly identified among worldwide P. 
vivax isolates. However, the overall pattern of genetic 
polymorphism of Korean PvAMA-1 slightly differed 
from those from other geographical isolates. Moreo-
ver, 29 novel polymorphic changes, most of which are 
predicted to be located outside B-cell epitopes, were 
also observed in Korean PvAMA-1. Genetic diversity 
of Korean PvAMA-1 was relatively lower than cur-
rently analyzed PvAMA-1 from other geographical 
areas, but evidences for natural selection and recom-
bination were found. These results have significant 
implications in understanding the nature of Korean P. 
vivax population and in providing useful information 
for malaria vaccine development based on this antigen.
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